2014 Annual Meeting of the American Society for Investigative Pathology
2014 Annual Meeting of the American Society for Investigative Pathology
批准号:
8716277
负责人:
FRANCIS W. LUSCINSKAS
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-24 至 2015-04-23
关键词:
AmericanAnimal ModelAnimalsAreaArtsAwardBasic ScienceBiochemistryBiologyBiomedical ResearchCancer BiologyCarcinomaCellsClinicalCommunitiesDevelopmentDiagnosticDiseaseEducational workshopEnsureExperimental PathologyFacultyFosteringGenomicsGoalsHumanInfectious AgentKnowledgeLinkMalignant NeoplasmsMalignant neoplasm of lungMediationMentorsMolecularMolecular BiologyNeoplasmsPathogenesisPathologyPharmaceutical SocietiesPhysiologicalPostdoctoral FellowPublishingResearchResearch PersonnelRoleScientistSocietiesSpecial EventStagingStem cellsTechniquesTestingTherapeuticTravelUnderrepresented MinorityWomanWorkWound Healingabstractingcardiac repaircareercareer developmentdesigngraduate studenthuman diseaseinnovationinsightinterestlecturesmeetingsmembernovelnutritionpostersprognosticprogramspublic health relevancestem cell biologysymposiumtherapy developmenttriple-negative invasive breast carcinomatumorigenesis
中文摘要
描述(由申请人提供):本提案的目的是寻求对美国研究病理学学会(ASIP)2014年年会的支持,该年会将于4月26-30日在圣地亚哥会议中心与实验生物学大会一起举行。ASIP年会为展示和分享实验病理学的前沿研究提供了一个独特的论坛。会议的目标受众和主题各不相同,但由于对疾病机制的共同关注而团结在一起。反映了ASIP成员的兴趣,2014年年会包括肿瘤方面的重要组成部分,包括三重阴性乳腺癌的发病机制;肿瘤发生的新机制;肺癌的个性化治疗;单细胞基因组学在肺癌解码方面的使用;利用动物模型开发人类癌症的治疗方法;伤口愈合与癌症之间的联系;感染性病原体在上皮性癌症中的作用;以及干细胞用于心脏修复。此外,几个会议将介绍与癌症研究直接相关的病理分析技术的进展。为期五天的课程包括两个创新的全天、单一主题的“会议中的会议”、研讨会、研讨会和获奖者的演讲,以及抽象驱动的迷你研讨会和海报会议。该计划还提供了一些教育倡议,既有针对性的,也有整个生物医学研究社区感兴趣的。这些会议包括关于科学出版中的诚信、有效谈判的艺术以及在研究中保护人类和动物对象的会议。ASIP将促进实习生和青年调查员的职业发展作为年会的一个极其重要的方面。因此,会议提供了针对他们的需要而设计的特别活动和展示他们工作的会议。同样,方案委员会努力确保妇女和代表性不足的少数群体的参与。这项申请的唯一具体目的是通过扩大旅行奖励和指导计划,并提供针对研究生、博士后研究员、临床住院医师和病理学研究员以及处于职业生涯早期阶段的教师的特别会议,促进受训人员和初级调查人员参与年会。
英文摘要
DESCRIPTION (provided by applicant): The purpose of this proposal is to seek support for the 2014 Annual Meeting of the American Society for Investigative Pathology (ASIP), which will be held at the San Diego Convention Center on April 26-30, in conjunction with the Experimental Biology convention. ASIP's Annual Meeting provides a unique forum for presentation and sharing of cutting-edge research in experimental pathology. The target audience and subject matter for the meeting are diverse but united by a common focus on mechanisms of disease. Reflecting the interests of the ASIP membership, the 2014 Annual Meeting includes strong components in neoplasia, including topics such as pathogenesis of triple-negative breast cancer; novel mechanisms of oncogenesis; personalized therapies for lung cancer; use of single-cell genomics to decode lung cancer; use of animal models to develop therapies for human cancer; links between wound healing and cancer; the role of infectious agents in epithelial carcinomas; and use of stem cells for cardiac repair. In addition, several sessions will present advances in techniques for pathological analysis that have direct relevance to the study of cancer. The five-day program comprises two innovative full-day, single-topic "meetings-within-a- meeting," symposia, workshops, and lectures by award recipients, as well as abstract-driven minisymposia and poster sessions. The program further provides a number of educational initiatives, both targeted and of interest to the biomedical research community as a whole. These include sessions on integrity in scientific publishing; the art of effective negotiation; and protection of human and animal subjects in research. ASIP regards promotion of the career development of trainee and young investigators as an extremely important aspect of the Annual Meeting. Accordingly, the meeting provides special events designed for their needs and sessions that showcase their work. Similarly, the Program Committee works hard to ensure participation of women and under-represented minorities. The sole specific aim of this application is to promote the participation of trainees and junior investigators in the Annual Meeting through expansion of travel award and mentoring programs and provision of special sessions targeted to graduate students, postdoctoral fellows, clinical residents and fellows in pathology, and faculty in the early stages of their careers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD47 Regulation of Leukocyte Integrins during Leukocyte Trafficking
-
批准号:9105867
-
项目类别:
-
资助金额:$58.46万
-
财政年份:2016
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
2013 Annual Meeting of the American Society for Investigative Pathology
-
批准号:8527049
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2013
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
The Role of CD47 in Mononuclear Leukocyte Recruitment
-
批准号:7753041
-
项目类别:
-
资助金额:$61.36万
-
财政年份:2009
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
Administrative Core
-
批准号:7753059
-
项目类别:
-
资助金额:$15.28万
-
财政年份:2009
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
Cell Biology Support
-
批准号:7753053
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2009
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
-
批准号:6602438
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2002
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
CORE--CELL BIOLOGY SUPPORT
-
批准号:6602444
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2002
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
-
批准号:6469264
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
CORE--CELL BIOLOGY SUPPORT
-
批准号:6469270
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
CORE--CELL BIOLOGY SUPPORT
-
批准号:6327723
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2000
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
-
批准号:6327717
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2000
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC IMMUNE DISEASES
-
批准号:6661274
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC IMMUNE DISEASES
-
批准号:6080816
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC IMMUNE DISEASES
-
批准号:6390760
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC IMMUNE DISEASES
-
批准号:6527578
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
-
批准号:6109793
-
项目类别:
-
资助金额:$32.32万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
CORE--CELL BIOLOGY SUPPORT
-
批准号:6109799
-
项目类别:
-
资助金额:$32.32万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC IMMUNE DISEASES
-
批准号:6185176
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1999
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
-
批准号:6272750
-
项目类别:
-
资助金额:$31.73万
-
财政年份:1998
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
CORE--CELL BIOLOGY SUPPORT
-
批准号:6272756
-
项目类别:
-
资助金额:$31.73万
-
财政年份:1998
-
负责人:FRANCIS W. LUSCINSKAS
-
依托单位:
海外基金